Have a personal or library account? Click to login
Myocardial performance index to assess cardiac function in spondyloarthritis: A systematic review and meta-analysis Cover

Myocardial performance index to assess cardiac function in spondyloarthritis: A systematic review and meta-analysis

Open Access
|Jul 2025

References

  1. GALARZA-DELGADO DA., AZPIRI-LOPEZ JR., COLUNGA-PEDRAZA IJ., CARDENASDE LA GARZA JA., GONZALEZ-GONZALEZ V., BELTRAN-AGUILAR VM., et al. Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic. Clin Rheumatol. 2023;42(10):2677–90.
  2. VAN DOORNUM S., BOHENSKY M., TACEY MA., BRAND CA., SUNDARARAJAN V., WICKS IP. Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease. Arthritis Res Ther. 2015;17(1):38.
  3. PRASAD M., HERMANN J., GABRIEL SE., WEYAND CM., MULVAGH S., MANKAD R., et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol. 2015;12(3):168–76.
  4. AGCA R., HESLINGA SC., ROLLEFSTAD S., HESLINGA M., MCINNES IB., PETERS MJL., et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17–28.
  5. KIM JH., CHOI IA. Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta-analysis. Int J Rheum Dis. 2021;24(4):477–86.
  6. HINTENBERGER R., AFFENZELLER B., VLADYCHUK V., PIERINGER H. Cardiovascular risk in axial spondyloarthritis—a systematic review. Clin Rheumatol. 2023;42(10):2621–33.
  7. TEI C., LING LH., HODGE DO., BAILEY KR., OH JK., RODEHEFFER RJ., et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy. J Cardiol. 1995;26(6):357–66.
  8. BENNETT S., WONG CW., GRIFFITHS T., STOUT M., KHAN JN., DUCKETT S., et al. The prognostic value of Tei index in acute myocardial infarction: a systematic review. Echo Res Pract. 2020;7(4):49–58.
  9. ROJO EC., RODRIGO JL., PÉREZ DE ISLA L., ALMERÍA C., GONZALO N., AUBELE A., et al. Disagreement between tissue Doppler imaging and conventional pulsed wave Doppler in the measurement of myocardial performance index. Eur J Echocardiogr. 2006;7(5):356–64.
  10. ROSA RE. Tei Index in a Sample of Patients with Ankylosing Spondylitis. J Rheum Dis Treat. 2015;1(2).
  11. ABUOMARA HZA., HASSAN OM., RASHID T., BARAKA M. Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction. Egypt Heart J. 2018;70(2):71–5.
  12. MERIC M., YESILDAG O., YUKSEL S., SOYLU K., ARSLANDAG M., DURSUN I., et al. Tissue Doppler myocardial performance index in patients with heart failure and its relationship with haemodynamic parameters. Int J Cardiovasc Imaging. 2014;30(6):1057–64.
  13. SHEEL BK., BADIUZZAMAN M., HAQUE T., RAHMAN H., BISWAS AK., KHAN SR. Association between Myocardial Performance Index (Tei-Index) and Severity of Coronary Artery Disease in Patients with Non-ST Segment Elevation Acute Coronary Syndrome. Bangladesh Heart J. 2022;37(1):16–26.
  14. KYRIAKOU P., MOUSELIMIS D., TSAROUCHAS A., RIGOPOULOS A., BAKOGIANNIS C., NOUTSIAS M., et al. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers. BMC Cardiovasc Disord. 2018;18:221.
  15. GOROSHI M., CHAND D. Myocardial Performance Index (Tei Index): A simple tool to identify cardiac dysfunction in patients with diabetes mellitus. Indian Heart J. 2016;68(1):83–7.
  16. LANG RM., BADANO LP., MOR-AVI V., AFILALO J., ARMSTRONG A., ERNANDE L., et al. Recommendations for cardiac chamber quantification by echocardiography in adults. J Am Soc Echocardiogr. 2015;28(1):1–39.e14.
  17. NAGUEH SF., SMISETH OA., APPLETON CP., BYRD BF., DOKAINISH H., EDVARDSEN T., et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. J Am Soc Echocardiogr. 2016;29(4):277–314.
  18. AKGÖL G., GÜLKESEN A., USLU EY., ALKAN G., BOLAYIR HA., GELEN MA., et al. Can myocardial dysfunction be detected in patients with rheumatoid arthritis with no cardiac symptoms? Eur Rev Med Pharmacol Sci. 2023;27(10):4399–405.
  19. LI X., CHEN H., HAN M., LUO Y., LIU F., CHEN L., et al. Quantitative assessment of left ventricular systolic function in patients with systemic lupus erythematosus. Quant Imaging Med Surg. 2022;12(6):3170–83.
  20. ACAR G., SAYARLIOGLU M., AKCAY A., SOKMEN A., SOKMEN G., ALTUN B., et al. Assessment of atrial electromechanical coupling characteristics in patients with ankylosing spondylitis. Echocardiography. 2009;26(5):549–57.
  21. SEDDIK EH., SHAKER A., HOSSENY AM., WAGEEH S. Role of 2D Speckle Tracking Echocardiography in Detection of Subclinical Cardiac Dysfunction in Ankylosing Spondylitis. Zagazig Univ Med J. 2023;29(5):1375–85.
  22. ROMAND X., ADELINE F., DALECKY M., PFLIMLIN A., BELLIER A., BARONEROCHETTE G., et al. Systematic assessment of heart valves and cardiac function by echocardiography in axial spondyloarthritis. Joint Bone Spine. 2022;89(4):105375.
  23. BOLAJI O., ORIAIFO O., ADABALE O., DILIBE A., KURUVADA K., OUEDRAOGO F., et al. A meta-analysis of left ventricular dysfunction in ankylosing spondylitis. J Clin Hypertens. 2024;26(7):772–88.
  24. BEZERRA CT., GRANDE AJ., GALVÃO VK., SANTOS DHMD., ATALLAH ÁN., SILVA V. Assessment of the strength of recommendation and quality of evidence: GRADE checklist. Sao Paulo Med J. 2022;140(6):829–36.
  25. KOCABAŞ H., ÖNCEL CR., KÜÇÜK M., YILDIRIM AB., KAÇAR C. Red Cell Distribution Width and Subclinical Left Ventricular Dysfunction in Patients with Ankylosing Spondylitis. Acta Med Alanya. 2018;2(2):96–101.
  26. MOYSSAKIS I., GIALAFOS E., VASSILIOU VA., BOKI K., VOTTEAS V., SFIKAKIS PP., et al. Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scand J Rheumatol. 2009;38(3):216–21.
  27. ALBAYRAK N., BAYRAM NA., ERTEN S., SARI C., KELES T., DURMAZ T., et al. The effects of undifferentiated spondyloarthropathy on left ventricular systolic and diastolic function. Int J Rheum Dis. 2013;16(2):162–7.
  28. KUCUK M., KORUCUK N., TOSUN V., CAVUSOGLU M., BASARICI I. Assessment of left atrial function using speckle tracking echocardiography in ankylosing spondylitis. Int J Cardiovasc Imaging. 2018;34(12):1863–8.
  29. ÖZMEN Ç., GÖKÇEN N., AKILLI R., YEŞILDAŞ C., USAL A. Could presystolic wave be a predictor for subclinical left ventricular diastolic dysfunction in ankylosing spondylitis? Cukurova Med J. 2020;45(3):880–90.
  30. OKAN T., SARI I., AKAR S., CECE H., GOLDELI O., GUNERI S., et al. Ventricular diastolic function of ankylosing spondylitis patients by using Doppler and Tei index. Echocardiography. 2008;25(1):47–56.
  31. KIRIS A., KARKUCAK M., KARAMAN K., KIRIS G., CAPKIN E., GOKMEN F., et al. Patients with Ankylosing Spondylitis Have Evidence of Left Ventricular Asynchrony. Echocardiography. 2012;29(6):661–7.
  32. NAGEEB GS., SATTAR ABA., OMRAN AA., ATFY M., EBRAHIM G. Ventricular diastolic dysfunction in ankylosing spondylitis patients without clinical evidence of cardiovascular disease. Egypt Rheumatol Rehabil. 2013;40(2):114–20.
  33. STOLWIJK C., BOONEN A., VAN TUBERGEN A., REVEILLE JD. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am. 2012;38(3):441–76.
  34. KANE GC., KARON BL., MAHONEY DW., REDFIELD MM., ROGER VL., BURNETT JC., et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA. 2011;306(8):856–63.
  35. ALJAROUDI W., ALRAIES MC., HALLEY C., RODRIGUEZ L., GRIMM RA., THOMAS JD., et al. Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction. Circulation. 2012;125(6):782–8.
  36. DALIMUNTHE NN., ALWI I., NASUTION SA., SHATRI H. The role of Tei index added to the GRACE risk score for prediction of in-hospital MACE after acute myocardial infarction. Rom J Intern Med. 2022;60(4):222–8.
  37. HO CY., SOLOMON SD. A Clinician’s Guide to Tissue Doppler Imaging. Circulation. 2006;113(10):e396–8.
  38. ALMASI S., FARAHANI B., SAMIEI N., REZAEI Y., MAHMOODI H., QORBANI M. Echocardiographic and Electrocardiographic Findings in Patients with Ankylosing Spondylitis without Cardiovascular Risk Factors. J Tehran Heart Cent. 2020;15(2):43–9.
  39. MIDTBØ H., SEMB AG., MATRE K., ROLLEFSTAD S., BERG IJ., GERTS E. Left Ventricular Systolic Myocardial Function in Ankylosing Spondylitis. Arthritis Care Res. 2019;71(9):1276–83.
  40. HESLINGA SC., VAN DONGEN CJ., KONINGS TC., PETERS MJ., VAN DER HORSTBRUINSMA IE., SMULDERS YM., et al. Diastolic left ventricular dysfunction in ankylosing spondylitis—a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(1):14–9.
  41. KELLY K. Ankylosing spondylitis and undifferentiated spondyloarthritis: The relationship between living with these diseases and psychological well-being. Musculoskeletal Care. 2021;19(2):158–64.
  42. XIA Q., FAN D., YANG X., LI X., ZHANG X., WANG M., et al. Progression rate of ankylosing spondylitis in patients with undifferentiated spondyloarthritis. Medicine (Baltimore). 2017;96(4):e5960.
  43. ASKIN L., YUCE EI., TANRIVERDI O. Myocardial performance index and cardiovascular diseases. Echocardiography. 2023;40(7):720–5.
DOI: https://doi.org/10.2478/rjim-2025-0013 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 191 - 208
Submitted on: Dec 19, 2024
|
Published on: Jul 12, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Steven Alvianto, Faisal Parlindungan, Naomi Niari Dalimunthe, Nicolas Daniel Widjanarko, Yovita Gotama, Ummi Kultsum, Cristopher Efendi, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.